PAQR5 and hepatocellular carcinoma: Additionally, analysis of clinicopathological characteristics in the TCGA cohort demonstrated that high PAQR5 expression was associated with advanced disease stages (Fig. 1H, Fig. S1B, C, E), reinforcing its potential role in HCC progression and as a prognostic marker.